...
首页> 外文期刊>Endocrine >Usefulness of NRAS codon 61 mutation analysis and core needle biopsy for the diagnosis of thyroid nodules previously diagnosed as atypia of undetermined significance
【24h】

Usefulness of NRAS codon 61 mutation analysis and core needle biopsy for the diagnosis of thyroid nodules previously diagnosed as atypia of undetermined significance

机译:NRAS 密码子 61 突变分析和空芯针活检对先前诊断为意义未明的异型性甲状腺结节的有用性

获取原文
获取原文并翻译 | 示例

摘要

A repeat fine needle aspiration (FNA) is recommended for thyroid nodules diagnosed as atypia of undetermined significance (AUS) in a previous cytology. We evaluated the utility of NRAS codon 61 (NRAS61) mutation analysis and core needle biopsy (CNB) for the diagnosis of thyroid nodules previously diagnosed as AUS. This study enrolled 236 patients who underwent both NRAS61 mutation analysis and CNB of thyroid nodules previously diagnosed as AUS at cytology. The NRAS61 mutation was detected in 36 nodules and was more frequently detected in the AUS and follicular neoplasm (FN)/suspicious for follicular neoplasm (SFN) categories, as determined by histological analysis of CNB, than in the benign group (p = 0.005). Sixty-one patients underwent surgery, and 29 nodules were finally diagnosed as malignant after surgery. Among 61 patients who underwent surgery, nodules with the NRAS61 mutation (42-65 ) had a significantly higher malignancy rate than nodules with wild-type NRAS61 (7-37 , p = 0.038). The association between malignancy and the NRAS61 mutation was significant after adjusting for age, sex, nodule size, and histological diagnosis of CNB (p = 0.01). NRAS61 mutation analysis together with CNB could be helpful for arriving at a clinical decision in patients with thyroid nodules showing AUS in a previous cytology.
机译:对于在既往细胞学检查中被诊断为意义不明的异型性 (AUS) 的甲状腺结节,建议进行重复细针穿刺 (FNA)。我们评估了NRAS密码子61(NRAS61)突变分析和空芯针活检(CNB)在诊断先前诊断为AUS的甲状腺结节方面的效用。本研究招募了 236 名患者,他们接受了 NRAS61 突变分析和先前在细胞学上诊断为 AUS 的甲状腺结节的 CNB。NRAS61 突变在 36 个结节中检测到,根据 CNB 的组织学分析确定,在 AUS 和滤泡性肿瘤 (FN)/可疑滤泡性肿瘤 (SFN) 类别中检测到的频率高于良性组 (p = 0.005)。61例患者接受了手术,29个结节经手术最终诊断为恶性。在61例接受手术的患者中,NRAS61突变结节(42-65%)的恶性发生率明显高于野生型NRAS61结节(7-37%,p = 0.038)。在调整 CNB 的年龄、性别、结节大小和组织学诊断后,恶性肿瘤与 NRAS61 突变之间的相关性显着 (p = 0.01)。NRAS61 突变分析与 CNB 一起可能有助于对既往细胞学检查中显示 AUS 的甲状腺结节患者做出临床决策。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号